Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
Rhea-AI Summary
Viatris (Nasdaq: VTRS) will report first quarter 2026 financial results on Thursday, May 7, 2026. Company executives will host a live webcast at 8:30 a.m. ET the same day to discuss results.
Investors can access the live webcast at investor.viatris.com, call 844.308.3344 (domestic) or 412.317.1896 (international). A replay will be available on the company website after the call.
Positive
- None.
Negative
- None.
News Market Reaction – VTRS
In the Apr 13 session, VTRS gained 2.67%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 03 | Earnings date notice | Neutral | +5.0% | Set Q4/FY2025 earnings date and investor event details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The last earnings date announcement saw a modestly positive move of about 4.97% on the day following the news.
This announcement sets the timing for Viatris’ Q1 2026 results, continuing a pattern seen with the prior earnings date release on Feb 3, 2026, which preceded fourth-quarter and full-year numbers. Around that earlier scheduling update, shares moved up 4.97%. Since then, Viatris has delivered FY2025 results, maintained its 2026 dividend policy, and advanced regulatory and clinical milestones, framing expectations as investors look toward the upcoming quarter’s disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a dynamic portfolio that spans generics, established brands and innovative medicines that address areas of significant unmet need. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-first-quarter-2026-financial-results-on-may-7-2026-302739369.html
SOURCE Viatris Inc.